IBUPROFEN

PRODUCT IDENTIFICATION

CAS NO. 15687-27-1

IBUPROFEN

EINECS NO. 239-784-6
FORMULA (CH3)2CHCH2C6H4CH(CH3)COOH
MOL WT. 206.29

H.S. CODE

2916.39

TOXICITY

ORL-RAT LD50:636 MG/KG
SYNONYMS 2-(4-isobutylphenyl)propionic Acid; Apsifen; Apsifen-F;
Alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid; Acide (Isobutyl-4 Phenyl)-2 Propionique (French); Ibuprocin; para-Isobutylhydratropic acid; (+/-)-2-(p-Isobutyl phenyl)propionic acid; (+)-2-(4-Isobutyl phenyl)propionic acid; 4-Isobutyl- alpha-methylphenylacetic acid; Ibufen; Ibuprin; Alpha-methyl-4-(2-Methylpropyl)- Benzeneacetic Acid;
SMILES

 

CLASSIFICATION

 

PHYSICAL AND CHEMICAL PROPERTIES

PHYSICAL STATE white crystalline powder
MELTING POINT 75 - 78
BOILING POINT  
SPECIFIC GRAVITY

 

SOLUBILITY IN WATER

Practically insoluble

pH  
VAPOR DENSITY

 

AUTOIGNITION

 

NFPA RATINGS  

REFRACTIVE INDEX

 
FLASH POINT

 

STABILITY

Stable under ordinary conditions

APPLICATIONS

Ibuprofen is a drug belong to a class of NSAID (nonsteroidal anti-inflammatory drug acts by inhibiting isoforms of cyclo-oxygenase 1 and 2. It has an activity to treat inflammatory  rheumatoid diseases and relieve acute pain. It is effective against period pains, pain after surgery, and fever.

Nonsteroidal Antiinflammatory Drugs (NSAIDs); chemically heterogeneous large groups of drugs which suppress inflammation in a manner similar to steroids, but less side effects of sedation, respiratory depression, or addiction than steroids. They are widely used for the treatment of inflammatory disorders and painful conditions such as rheumatoid arthritis, gout, bursitis, painful menstruation, and headache. They are effective in the relief of pain and fever. NSAIDs inhibit the cyclooxygenase (COX) activity resulting in decreased synthesis of prostaglandin, leukotriene and thromboxane precursors such as the ubiquitous enzyme which catalyzes the initial step in the synthesis of prostanoids. Prostanoid is any of a group of C-20 fatty acids complex with an internal five or six carbon rings such as prostaglandins, prostanoic acid, prostacyclins, and thromboxane; derived from arachidonic acid (C-20 polyunsaturated fatty acid with four cis double bonds). The action or the synthesis of prostanoids are involved in the modulation of a variety of pathophysiologic processes including inflammation, hemostasis, thrombosis, cytoprotection,  ulceration, hemodynamics and other the progression of kidney diseases. Thus, NSAIDs as non-selective inhibitors of the cyclooxygenases (both the cyclooxygenase-1 and cyclooxygenase-2 isoenzymes) may have beneficial as well as untoward effects on a variety of human diseases. Low stomach prostanoid levels caused by COX-1 inhibitors can result in ulceration and internal bleeding and perforation. The selective COX-2 inhibitors such as oxicam, meloxicam, and coxibs (celecoxib, rofecoxib, valdecoxib, parecoxib and etoricoxib) do not interfere with COX-1. The most prominent NSAID is aspirin. Nonaspirin NSAIDs can be classified based on chemical structures.

Nonsteroidal Anti-Inflammatory Drugs (NSAID) by chemical structure

  • Carboxylic Acid Groups
    • Salicylates (Acetylsalicylate, Choline salicylate, Diflunisal, Magnesium choline salicylate, Magnesium salicylate, Salsalate)
    • Acetic Acids (Bendazac, Diclofenac, Etodolac, Indomethacin, Ketorolac, Nabumetone, Sulindac, Tolmetin)
    • Propionic acids (Carprofen, Fenoprofen, Flurbiprofen, Ibuprofen, Ketoprofen, Loxoprofen, Naproxen, Naproxen sodium, Oxaprozin, Vedaprofen)
    • Anthranilic acids (Meclofenamic acid, Meclofenamate sodium, Tolfenamic acid)
    • Phenylacetic acids
    • Aminonicotinic acids (Flunixin)
    • Indole Analogs (Indomethacin, Nabumetone, Ketorolac, Etodolac,)
  • Enolic Acid Groups (which doesn't have carboxylic group but acid due to the enolic hydroxy substituent)
    • Pyrazolones (Phenylbutazone, Oxyphenbutazone, Dipyrone, Ramifenazone)
    • Oxicams (Meloxicam, Piroxicam, Tenoxicam)
  • Coxibs
    • Celecoxib, Rofecoxib, Valdecoxib, Parecoxib, Etoricoxib
  • Gold Salts
    • Auranofin, Gold sodium thiomalate, Aurothioglucose

SALES SPECIFICATION

BIBLIOGRAPHY

BP93

APPEARANCE

white crystalline powder

ASSAY

98.5%-101.0%
CLARITY OF SOLUTION clear and colourless (10% solution in methanol)

OPTICAL ROTATION

-0.05 ~ +0.05
HEAVY METALS 10ppm max
MELTING POINT 74 C min

SULPHATED ASH

0.1% max
LOSS ON DRYING 0.5% max
TRANSPORTATION
PACKING
25kgs in fiber drum
HAZARD CLASS  
UN NO.  
PRICE

Click to open the table

 

Click to close the table